JPMORGAN CHASE & CO - BIOHAVEN PHARMACTL HLDG CO L ownership

BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 309 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q1 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.7%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of BIOHAVEN PHARMACTL HLDG CO L
ValueSharesWeighting
Q3 2022$308,646,000
+141.6%
2,041,718
+132.9%
0.04%
+144.4%
Q2 2022$127,726,000
-21.3%
876,584
-36.0%
0.02%
-10.0%
Q1 2022$162,386,000
-15.5%
1,369,533
-1.8%
0.02%
-9.1%
Q4 2021$192,261,000
-5.2%
1,395,125
-4.4%
0.02%
-12.0%
Q3 2021$202,772,000
+19.2%
1,459,739
-16.7%
0.02%
+25.0%
Q2 2021$170,072,000
+41.8%
1,751,868
-0.1%
0.02%
+25.0%
Q1 2021$119,917,000
-16.5%
1,754,456
+4.7%
0.02%
-23.8%
Q4 2020$143,647,000
+36.9%
1,675,962
+0.9%
0.02%
+16.7%
Q3 2020$104,934,000
-10.7%
1,661,411
+3.3%
0.02%
-21.7%
Q2 2020$117,550,000
+125.0%
1,607,854
+4.7%
0.02%
+91.7%
Q1 2020$52,251,000
-33.1%
1,535,445
+7.0%
0.01%
-20.0%
Q4 2019$78,100,000
+22.0%
1,434,593
-6.5%
0.02%
+15.4%
Q3 2019$64,017,000
-2.6%
1,534,444
-0.8%
0.01%0.0%
Q2 2019$65,750,000
-27.8%
1,546,712
-12.6%
0.01%
-31.6%
Q1 2019$91,081,000
+29.9%
1,769,613
-6.7%
0.02%
+18.8%
Q4 2018$70,113,000
+21.9%
1,895,960
+23.7%
0.02%
+45.5%
Q3 2018$57,540,000
+2.1%
1,532,361
+7.4%
0.01%
-8.3%
Q2 2018$56,373,000
+138.5%
1,426,448
+55.5%
0.01%
+140.0%
Q1 2018$23,632,000
-4.7%
917,343
-0.2%
0.01%0.0%
Q4 2017$24,802,000
+36.5%
919,280
+92.2%
0.01%
+25.0%
Q3 2017$18,173,000
+22.5%
478,253
-19.4%
0.00%
+33.3%
Q2 2017$14,831,000593,2250.00%
Other shareholders
BIOHAVEN PHARMACTL HLDG CO L shareholders Q1 2022
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 490,422$12,755,87613.24%
FNY Investment Advisers, LLC 30$00.00%
View complete list of BIOHAVEN PHARMACTL HLDG CO L shareholders